Status epilepticus nonconvulsive

Additionally, there have been postmarketing reports cognitive/neuropsychiatric symptoms, some accompanied by EEG abnormalities such as generalized spike and wave activity, that have been reported as nonconvulsant status epilepticus. 

Roccatagliata L, Audenino D, Primavera A, Cocito L. Nonconvulsive status epilepticus from accidental lithium ingestion. Am J Emerg Med 2002 20(6) 570-2. 

Yoshino A, Yoshimasu H, Tatsuzawa Y, Asakura T, Hara T. Nonconvulsive status epilepticus in two patients with neuroleptic malignant syndrome. J Clin Psychopharmacol 1998 18(4) 347-9. 

A patient presented with nonconvulsive status epilepticus and a serum lithium concentration of 1.9 mmol/1 (122). 

Eckardt KM, Steinhoff BJ. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia 1998 39(6) 671. ... 

Ettinger AB, Bernal OG, Andriola MR, Bagchi S, Flores P, Just C, Pitocco C, Rooney T, Tuominen J, Devinsky O. Two cases of nonconvulsive status epilepticus in association with tiagabine therapy. Epilepsia 1999 40(8) 1159-62. 

Piccinelli P, Borgatti R, Perucca E, Tofani A, Donati G, Balottin U. Frontal nonconvulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria. Epilepsia 2000 41(ll) 1485-8. 

Fitzek S, Hegemann S, Sauner D, Bonsch D, Fitzek C. Drug-induced nonconvulsive status epilepticus with low dose of tiagabine. Epileptic Disord 2001 3(3) 147-50. 

There are two types of status epilepticus, generalized con- vulsive status epilepticus (GCSE) and nonconvulsive status epilepticus (NCSE). GCSE is the most common type. 

Walker MC. Diagnosis and treatment of nonconvulsive status epilepticus. CNS Drugs 2001 15 931-939. 

Hovinga CA, Chicella MF, Rose DF, et al. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Ann Pharmacother 1999 33 579-584. 

Side effects are more common with tiagabine than with other adjunct drugs and most often involve the CNS. They include somnolence, headache, dizziness, tremor, abnormal thinking, depression, and psychosis. Furthermore, recent reports have implicated tiagabine in the development of nonconvulsive status epilepticus (88,89). There is an increased risk of seizure in patients being treated for off-label psychiatric indications. Tiagabine may interfere with visual color perception (90). 

Pang T, Hirsch LJ. Treatment of convulsive and nonconvulsive status epilepticus. Current Treatment Options in Neurology 2005 7 247-259. 

Treiman DM, Waiker MC. Treatment of seizure emergencies convulsive and nonconvulsive status epilepticus. Epilepsy Res 2006 68(Suppl 1) S77-S82. 

Ebner A, May TW. Topiramate overdose a case report of a patient with extremely high topiramate serum concentrations and nonconvulsive status epilepticus. Epilepsia 2010 51(6) 1090-3. 

Lichaa H, Rachoin IS, Cerceo E, Rajput V, Surkis W. Cefepime an underrecognized cause of nonconvulsive status epilepticus. J Hosp Med 2010 5(3) E18-9. 

Nobutoki T, Takahashi JY, Ihara T. A 5-year-old boy with nonconvulsive status epilepticus induced by theophylline treatment. No To Hattatsu 2008 40(4) 328-32. 

A 60-year-old male with known cerebral palsy and epilepsy on phenytoin and clobazam, presented to emergency department with a community-acquired pneumonia which was treated with levofloxacin. Phenytoin levels on admission were high and therefore phenytoin was omitted until levels were in the therapeutic range. Ten days into admission, he developed status epilepticus that necessitated intubation and ventilation for airway protection. Continuous EEC monitoring showed nonconvulsive status epilepticus. 

---